AverapHarm.com
About AverapHarm.com
Avera is a specialty pharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical compounds.To date, Avera has built a strong pipeline by acquiring high-value assets from Novartis AG, Eli Lilly & Co., and GlaxoSmithKline. Through in-licensing, Avera will continue to build its pipeline of novel, clinical-stage assets that address areas of significant unmet medical need.Avera’s greatest strength and expertise is in drug development.
